Treatment Approaches for TP53-Mutated AML | OncLive
Treatment Approaches for TP53-Mutated AML | OncLive
Sep 9, 2021
onclive.com
FLT3-Mutated AML: Early Aggressive Therapy vs Transplant
FLT3-Mutated AML: Early Aggressive Therapy vs Transplant
Jul 20, 2020
onclive.com
Understanding Anti-Money Laundering (AML): Key Processes and Global Impact
Understanding Anti-Money Laundering (AML): Key Processe…
4 months ago
investopedia.com
Activity, Tolerability and Resistance Profile of the Menin Inhibitor Ziftomenib in Adults With Relapsed or Refractory NPM1-Mutated AML
Activity, Tolerability and Resistance Profile of the Menin Inhibitor Zifto…
Jul 12, 2023
onclive.com
Unmet Needs for Patients With AML | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Unmet Needs for Patients With AML | Targeted Oncology - Immunother…
Jan 3, 2024
targetedonc.com
Phase 1b Study of Azacitidine, Venetoclax and Revumenib in Newly Diagnosed Older Adults with NPM1 Mutated or KMT2A Rearranged AML: Interim Results of Dose Escalation from the Beat AML Consortium | OncLive
13:50
Phase 1b Study of Azacitidine, Venetoclax and Revumenib in Ne…
1 week ago
onclive.com
Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde
Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde
632 viewsJul 11, 2024
vumedi.com
Retesting for FLT3 Mutation Status in AML | OncLive
Jul 9, 2019
onclive.com
Dr Fedorov on the Use of Quizartinib vs Midostaurin in FLT3 AML | Onc…
Apr 26, 2024
onclive.com
Treatment Options for AML Patients with IDH2, RUNX1, or DNMT3A Mu…
Aug 8, 2022
targetedonc.com
12:59
Approaches to managing FLT3-mutant AML
175 views3 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:08
Could MRD become a surrogate endpoint for drug approval in AML?
29 views3 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
11:48
Ask the Expert: Naval Daver answers your AML questions at iw…
100 views3 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:57
Ziftomenib with azacitidine and venetoclax in NPM1-mutated AML…
35 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:39
The VICEROY study: VEN/AZA/GILT in newly diagnosed FLT3-mutated …
16 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:22
FDA Approves Ziftomenib for Relapsed/Refractory NPM1-Mutate…
1 views1 month ago
YouTubeThe Spectrum Room
1:30
KOMET-001 Study Design: Which Led to the FDA approval of Ziftom…
300 views1 month ago
YouTubeOncology Brothers Clips
2:19
Updated results from the AUGMENT-101 study: revumenib …
62 views3 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
16:15
Approaching TP53-mutated AML: current challenges, ongoing resea…
354 views3 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:54
The current standard of care for IDH-mutated AML & combination…
37 views3 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
21:29
iwAL 2025 highlights: resistance mechanisms in AML, novel targets…
71 views3 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
5:56
Treating AML
68.1K viewsNov 27, 2019
YouTubeYou and AML
6:35
Understanding AML
171.2K viewsDec 2, 2019
YouTubeYou and AML
Azacitidine, venetoclax & gilteritinib in older/unfit patients with FLT3-m…
728 viewsJun 20, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
Scientists Reveal 51 Mutations Linked to Changes in ALS Risk | C…
Nov 3, 2024
labroots.com
Eprenetapopt plus venetoclax and azacitidine in the treatment of TP5…
518 viewsFeb 24, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
MRD negativity in NPM1-mutated AML: the influence of co-occurrin…
171 viewsDec 13, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
Secondary-type mutations do not impact the favorable prognosis in …
319 viewsFeb 21, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
7:02
Acute Myeloid Leukemia (AML)
21K viewsAug 25, 2013
YouTubeNEJM Group
1:27
What Is AML?
23.1K viewsApr 19, 2018
YouTubeBlood Cancer United
See more videos
Static thumbnail place holder